Trauma Devices – Market Insights – United States

Long-term growth of the US trauma device market will be driven by the uptake of novel technologies such as 3-D printed implants, the expansion of the foot and ankle device segment, site-of-service flexibility, and strategic mergers and acquisitions among companies offering complementary solutions. However, bulk purchasing by US hospitals will drive ASPs down, hindering market growth.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for trauma devices in the US from 2019 through 2034.

An increase in the volume of trauma device procedures in the US will mainly be driven by moderate growth in certain high-volume segments.

Which anatomic segments contribute most strongly to overall procedure volumes?

Which anatomic segments are seeing increased interest from competitors, and why?

Which device segments are seeing declines, and what is contributing to this?

How are procedural trends shifting due to improved technology and clinical data?

MNCs are the leading competitors in the US trauma device market.

Which MNCs have the strongest presence in the US market?

What strategies have MNCs leveraged to maintain their shares and remain competitive?

What strategies are smaller competitors using to gain market share?

The impact of the reimbursement landscape for trauma procedures performed in ASC settings encourage a shift to outpatient and ASC settings for certain anatomies.

Procedures for which anatomies are experiencing a site-of-service shift?

Which other value-based incentives and reimbursement model changes are impacting the US trauma device market?

Several manufacturers have recently diversified their product portfolios by introducing new devices or acquiring companies with complementary products.

Which competitors are using the breadth of their product portfolios to sustain or increase their trauma device market shares?

How are competitors expanding their offerings through product innovation, mergers, acquisitions, and/or partnerships to capture a larger share of the trauma device market?